Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
At 5mg/mL concentration, an 8mg dose requires 1.6mL, which is a large subcutaneous injection
A 2024 review in Diabetes Care confirmed that GI symptoms remain among the most common limitations of GLP-1 therapy and a leading reason people stop treatment (Drucker, 2024)
These are excellent adjuncts to your program but should be viewed as part of your support system, not the primary driver of significant weight loss
This error propagates because most patients starting tirzepatide receive 10 mg/mL vials, so "25 units = 2.5 mg" happens to be correct for the majority
The Bottom Line for Cash-Pay Patients Without Insurance The majority of people currently searching for GLP-1 programs online are cash-pay patients
